https://pharmadog.xyz/news/250431 pharmadog en 2026-08-15T10:00:56.000Z Trump orders MMR vaccine as LSD-targeted drug passes Phase 3 trial https://pharmadog.xyz/news/248145 pharmadog en 2026-08-14T23:07:00.000Z The Hampton Grocers recalls 8-oz Lacnola Lactation Granola over possible Salmonella contamination https://pharmadog.xyz/news/246659 pharmadog en 2026-08-14T21:00:08.000Z FTC launches antitrust probe into Epic Systems over alleged anticompetitive practices https://pharmadog.xyz/news/245942 pharmadog en 2026-08-14T18:34:30.000Z Pediatricians push back against vaccine fear-mongering by federal leaders https://pharmadog.xyz/news/245739 pharmadog en 2026-08-14T17:44:45.000Z Cytokinetics sues Bristol Myers Squibb over recently granted patent, intensifying rivalry https://pharmadog.xyz/news/245622 pharmadog en 2026-08-14T17:11:14.000Z Biotech firm Biogen secures Chinese approval for felzartamab in second-line multiple myeloma https://pharmadog.xyz/news/245450 pharmadog en 2026-08-14T16:30:39.000Z UnitedHealthcare CEO Brian Thompson killed; suspect Luigi Mangione pleads guilty to federal stalking https://pharmadog.xyz/news/245451 pharmadog en 2026-08-14T16:20:43.000Z Formation Bio appoints Michael Ehlers as chief scientific officer and head of R&D https://pharmadog.xyz/news/245351 pharmadog en 2026-08-14T16:02:00.000Z FDA grants accelerated approval to Bristol Myers' Zenbexus, first CELMoD for multiple myeloma https://pharmadog.xyz/news/245311 pharmadog en 2026-08-14T15:55:13.000Z FDA grants accelerated approval to Bristol's Zenbexus for multiple myeloma; PBMs adopt TrumpRx pricing; Novartis wins UK Entresto patent https://pharmadog.xyz/news/245130 pharmadog en 2026-08-14T15:33:45.000Z Capricor to submit additional data to FDA after negative advisory committee vote on Duchenne therapy https://pharmadog.xyz/news/245291 pharmadog en 2026-08-14T15:32:22.000Z Capricor Therapeutics sees stock surge as FDA signals openness to extend review of DMD cell therapy https://pharmadog.xyz/news/245131 pharmadog en 2026-08-14T15:30:52.000Z Redx Pharma pursues new reverse merger with Skye after 2023 setback https://pharmadog.xyz/news/245132 pharmadog en 2026-08-14T15:28:46.000Z Abcuro raises $66 million to launch Phase 3 trial in muscle-weakening disease after earlier setback https://pharmadog.xyz/news/245133 pharmadog en 2026-08-14T15:15:46.000Z ICER finds AstraZeneca’s blood pressure pill Baxfendy not cost-effective at $10,950 a year https://pharmadog.xyz/news/244914 pharmadog en 2026-08-14T14:10:55.000Z MapLight Therapeutics pauses early‑stage programs to focus on lead schizophrenia and Alzheimer’s psychosis candidate https://pharmadog.xyz/news/244819 pharmadog en 2026-08-14T14:00:17.000Z FDA approves Bristol Myers' first oral therapy for advanced multiple myeloma, a new drug class https://pharmadog.xyz/news/245095 pharmadog en 2026-08-14T13:28:00.000Z Capricor shares jump as FDA signals openness to review updated Duchenne therapy https://pharmadog.xyz/news/244682 pharmadog en 2026-08-14T13:23:06.000Z Drug-testing lab sues US Pharmacopeia over alleged false statements about testing methods https://pharmadog.xyz/news/245873 pharmadog en 2026-08-14T12:28:00.000Z Skye Bioscience and Redx Pharma combine to form Fibrx Therapeutics with $125M financing for fibrosis pipeline https://pharmadog.xyz/news/244435 pharmadog en 2026-08-14T12:03:41.000Z FDA clears Bristol Myers' Zenbexus, first drug of a new class for advanced multiple myeloma